Active, not recruitingPhase 3NCT06431373

A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis

Studying Anterior uveitis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Priovant Therapeutics, Inc.
Intervention
Brepocitinib PO QD(drug)
Enrollment
371 enrolled
Eligibility
18-75 years · All sexes
Timeline
2024 – 2028

Study locations (30)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06431373 on ClinicalTrials.gov

Other trials for Anterior uveitis

Additional recruiting or active studies for the same condition.

See all trials for Anterior uveitis →

← Back to all trials